Telemedicine and remote monitoring strategies, including virtual visits and implantable devices, provide safe and effective alternatives to in-person visits for managing heart failure.
Telemedicine and remote monitoring strategies have become routine in heart failure management, necessitating structured approaches tailored to patient risk profiles and attention to educational and cultural barriers to prevent disparities.
In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared. Virtual visits and telemonitoring strategies became routine. Evidence is accumulating regarding the safety and efficacy of virtual visits to replace in-person visits. A structured approach to virtual encounters is recommended. Telemonitoring includes patient reported remote vital sign monitoring, information from wearable devices, cardiac implantable electronic devices and invasive remote hemodynamic monitoring. The intensity of the monitoring should match the risk profile of the patient. Attention to cultural and educational barriers is important to prevent disparities in telehealth implementation.
Alvarez et al. (Wed,) conducted a review in Heart failure. Telemedicine and remote monitoring vs. In-person visits or usual care was evaluated. Telemedicine and remote monitoring strategies, including virtual visits and implantable devices, provide safe and effective alternatives to in-person visits for managing heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: